Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ctcfl
|
ENSMUSG00000070495.5 | CCCTC-binding factor (zinc finger protein)-like |
Ctcf
|
ENSMUSG00000005698.9 | CCCTC-binding factor |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr8_105635968_105636474 | Ctcf | 347 | 0.617571 | 0.63 | 2.2e-07 | Click! |
chr8_105636679_105636841 | Ctcf | 175 | 0.704417 | 0.62 | 5.4e-07 | Click! |
chr8_105636894_105637261 | Ctcf | 11 | 0.675023 | 0.56 | 7.0e-06 | Click! |
chr8_105636501_105636656 | Ctcf | 1 | 0.881252 | 0.55 | 1.4e-05 | Click! |
chr2_173119197_173119348 | Ctcfl | 253 | 0.686275 | 0.35 | 8.0e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_99151276_99151634 | 20.48 |
Gm45185 |
predicted gene 45185 |
9862 |
0.12 |
chr9_121697835_121697986 | 20.08 |
Sec22c |
SEC22 homolog C, vesicle trafficking protein |
4868 |
0.12 |
chr16_11423409_11423900 | 18.96 |
Snx29 |
sorting nexin 29 |
2946 |
0.31 |
chr11_103102675_103103532 | 17.99 |
Acbd4 |
acyl-Coenzyme A binding domain containing 4 |
5 |
0.95 |
chr10_127508848_127510720 | 15.43 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr9_100643446_100643943 | 14.09 |
Stag1 |
stromal antigen 1 |
58 |
0.97 |
chr5_140439026_140439687 | 14.07 |
Eif3b |
eukaryotic translation initiation factor 3, subunit B |
586 |
0.63 |
chr5_143731658_143732384 | 12.18 |
Usp42 |
ubiquitin specific peptidase 42 |
259 |
0.91 |
chr9_121697435_121697771 | 12.00 |
Sec22c |
SEC22 homolog C, vesicle trafficking protein |
4561 |
0.12 |
chr17_84114057_84114253 | 11.83 |
Gm19696 |
predicted gene, 19696 |
21805 |
0.14 |
chr6_88915651_88916398 | 11.71 |
Gm44178 |
predicted gene, 44178 |
3684 |
0.14 |
chr1_192745227_192745396 | 11.59 |
Gm22265 |
predicted gene, 22265 |
260 |
0.92 |
chr1_86501052_86501969 | 11.54 |
Ptma |
prothymosin alpha |
25216 |
0.11 |
chr5_135616151_135616323 | 11.09 |
Gm43123 |
predicted gene 43123 |
1062 |
0.36 |
chr4_139337211_139337402 | 11.00 |
AL807811.1 |
aldo-keto reductase family 7 member A2 (AKR7A2) pseudogene |
126 |
0.84 |
chr8_85397625_85397796 | 10.75 |
Mylk3 |
myosin light chain kinase 3 |
11365 |
0.13 |
chr11_113172483_113173067 | 10.30 |
2610035D17Rik |
RIKEN cDNA 2610035D17 gene |
302 |
0.93 |
chr10_127512528_127514054 | 10.26 |
Ndufa4l2 |
Ndufa4, mitochondrial complex associated like 2 |
1676 |
0.21 |
chr16_8769143_8769401 | 10.20 |
Gm25805 |
predicted gene, 25805 |
2996 |
0.23 |
chr1_167369953_167370207 | 10.17 |
Aldh9a1 |
aldehyde dehydrogenase 9, subfamily A1 |
5914 |
0.14 |
chr11_4094091_4094832 | 9.60 |
Mtfp1 |
mitochondrial fission process 1 |
679 |
0.5 |
chr12_105027552_105028075 | 9.54 |
Gm47650 |
predicted gene, 47650 |
150 |
0.9 |
chr9_66158067_66158548 | 9.52 |
Dapk2 |
death-associated protein kinase 2 |
72 |
0.97 |
chr15_83607515_83607715 | 9.51 |
Scube1 |
signal peptide, CUB domain, EGF-like 1 |
6124 |
0.16 |
chr15_99595954_99596704 | 9.37 |
Aqp5 |
aquaporin 5 |
3881 |
0.12 |
chr5_134918162_134918353 | 9.34 |
4933439J24Rik |
RIKEN cDNA 4933439J24 gene |
1531 |
0.18 |
chr18_42510920_42511513 | 9.32 |
Tcerg1 |
transcription elongation regulator 1 (CA150) |
271 |
0.91 |
chr7_28867795_28867957 | 9.19 |
Lgals7 |
lectin, galactose binding, soluble 7 |
3421 |
0.11 |
chr6_38911263_38911582 | 9.05 |
Tbxas1 |
thromboxane A synthase 1, platelet |
7558 |
0.21 |
chr11_101057938_101058139 | 8.86 |
Naglu |
alpha-N-acetylglucosaminidase (Sanfilippo disease IIIB) |
11974 |
0.08 |
chr11_80086905_80087159 | 8.86 |
Atad5 |
ATPase family, AAA domain containing 5 |
2368 |
0.24 |
chr4_117146298_117146472 | 8.83 |
Best4-ps |
bestrophin 4, pseudogene |
1128 |
0.2 |
chr7_27526560_27526737 | 8.62 |
Hipk4 |
homeodomain interacting protein kinase 4 |
411 |
0.7 |
chr1_191288876_191289044 | 8.50 |
Gm37168 |
predicted gene, 37168 |
21782 |
0.12 |
chr19_6969291_6970359 | 8.45 |
Plcb3 |
phospholipase C, beta 3 |
11 |
0.93 |
chr9_65196833_65197269 | 8.45 |
Gm25313 |
predicted gene, 25313 |
364 |
0.76 |
chr5_23850355_23851323 | 8.36 |
2700038G22Rik |
RIKEN cDNA 2700038G22 gene |
238 |
0.81 |
chr4_152096036_152096226 | 8.36 |
Plekhg5 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
588 |
0.63 |
chr19_5529422_5529603 | 8.29 |
Gm31166 |
predicted gene, 31166 |
2118 |
0.12 |
chr2_173586578_173586927 | 8.28 |
Ppp4r1l-ps |
protein phosphatase 4, regulatory subunit 1-like, pseudogene |
4010 |
0.22 |
chr12_84876857_84877053 | 8.28 |
Ltbp2 |
latent transforming growth factor beta binding protein 2 |
423 |
0.69 |
chr7_141008925_141009337 | 8.18 |
Ifitm3 |
interferon induced transmembrane protein 3 |
1639 |
0.17 |
chr2_72398360_72398532 | 7.92 |
Rpl36a-ps4 |
ribosomal protein L36A, pseudogene 4 |
38199 |
0.16 |
chr7_135680390_135680541 | 7.90 |
5830432E09Rik |
RIKEN cDNA 5830432E09 gene |
28151 |
0.12 |
chr19_55218273_55219120 | 7.89 |
Gucy2g |
guanylate cyclase 2g |
22540 |
0.14 |
chr5_150673675_150673876 | 7.87 |
Pds5b |
PDS5 cohesin associated factor B |
36 |
0.96 |
chr12_110992350_110992564 | 7.85 |
6030440G07Rik |
RIKEN cDNA 6030440G07 gene |
1941 |
0.21 |
chr4_139330680_139330867 | 7.84 |
AL807811.1 |
aldo-keto reductase family 7 member A2 (AKR7A2) pseudogene |
6407 |
0.08 |
chr10_77566751_77566970 | 7.83 |
Pttg1ip |
pituitary tumor-transforming 1 interacting protein |
14860 |
0.1 |
chr15_88876452_88876623 | 7.79 |
Pim3 |
proviral integration site 3 |
11617 |
0.13 |
chr11_116625659_116625821 | 7.74 |
Rhbdf2 |
rhomboid 5 homolog 2 |
1279 |
0.27 |
chr11_98597446_98597597 | 7.72 |
Lrrc3c |
leucine rich repeat containing 3C |
770 |
0.47 |
chr9_106643230_106643381 | 7.69 |
Gm28111 |
predicted gene 28111 |
2377 |
0.18 |
chr19_45016824_45017769 | 7.68 |
Lzts2 |
leucine zipper, putative tumor suppressor 2 |
799 |
0.44 |
chr7_4940310_4940494 | 7.67 |
Ssc5d |
scavenger receptor cysteine rich family, 5 domains |
3312 |
0.09 |
chr7_141394907_141395068 | 7.60 |
Taldo1 |
transaldolase 1 |
2744 |
0.1 |
chr2_28592938_28593096 | 7.60 |
Gm22675 |
predicted gene, 22675 |
2110 |
0.18 |
chr13_23697544_23698095 | 7.52 |
H4c3 |
H4 clustered histone 3 |
635 |
0.35 |
chr5_149678355_149679261 | 7.47 |
B3glct |
beta-3-glucosyltransferase |
578 |
0.71 |
chr2_32713345_32713794 | 7.46 |
Cdk9 |
cyclin-dependent kinase 9 (CDC2-related kinase) |
493 |
0.34 |
chr4_41129516_41129688 | 7.45 |
Gm12402 |
predicted gene 12402 |
3242 |
0.13 |
chr4_149793233_149793550 | 7.41 |
Gm13065 |
predicted gene 13065 |
28 |
0.95 |
chr11_80873165_80873425 | 7.38 |
Spaca3 |
sperm acrosome associated 3 |
14923 |
0.18 |
chr5_122925589_122925761 | 7.36 |
Kdm2b |
lysine (K)-specific demethylase 2B |
3568 |
0.17 |
chr1_132520821_132521022 | 7.32 |
Cntn2 |
contactin 2 |
1764 |
0.28 |
chr2_79265730_79265889 | 7.29 |
Itga4 |
integrin alpha 4 |
9862 |
0.23 |
chr17_5890554_5890733 | 7.29 |
Gm8376 |
predicted gene 8376 |
48444 |
0.09 |
chr5_140204146_140204297 | 7.28 |
Gm16120 |
predicted gene 16120 |
3164 |
0.23 |
chr19_41442695_41442846 | 7.21 |
Gm9788 |
predicted pseudogene 9788 |
17043 |
0.2 |
chr5_139803949_139804524 | 7.15 |
Tmem184a |
transmembrane protein 184a |
3744 |
0.14 |
chr5_140438814_140439011 | 7.13 |
Eif3b |
eukaryotic translation initiation factor 3, subunit B |
1030 |
0.4 |
chr11_97432110_97432278 | 7.11 |
Arhgap23 |
Rho GTPase activating protein 23 |
4091 |
0.19 |
chr15_102017591_102018334 | 7.07 |
Krt18 |
keratin 18 |
10218 |
0.11 |
chr5_120134115_120134293 | 6.99 |
Gm10390 |
predicted gene 10390 |
5057 |
0.22 |
chr10_80114596_80114882 | 6.94 |
Stk11 |
serine/threonine kinase 11 |
1064 |
0.3 |
chr14_69324528_69324690 | 6.92 |
Gm16677 |
predicted gene, 16677 |
12473 |
0.09 |
chr14_69542778_69542940 | 6.92 |
Gm27174 |
predicted gene 27174 |
12473 |
0.1 |
chr2_167680014_167680200 | 6.89 |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
8808 |
0.11 |
chr2_133431212_133431365 | 6.89 |
A430048G15Rik |
RIKEN cDNA A430048G15 gene |
807 |
0.69 |
chr15_99099214_99099571 | 6.80 |
Dnajc22 |
DnaJ heat shock protein family (Hsp40) member C22 |
20 |
0.95 |
chr11_113865723_113865957 | 6.78 |
Sdk2 |
sidekick cell adhesion molecule 2 |
39621 |
0.17 |
chr11_58916994_58917203 | 6.74 |
Btnl10 |
butyrophilin-like 10 |
810 |
0.34 |
chr19_44373066_44373243 | 6.73 |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
33536 |
0.1 |
chr2_180275758_180276275 | 6.70 |
Cables2 |
CDK5 and Abl enzyme substrate 2 |
2520 |
0.18 |
chr4_138319622_138319795 | 6.69 |
Pink1 |
PTEN induced putative kinase 1 |
3282 |
0.13 |
chr19_10240422_10240952 | 6.67 |
Myrf |
myelin regulatory factor |
58 |
0.96 |
chr8_13213963_13214189 | 6.65 |
2810030D12Rik |
RIKEN cDNA 2810030D12 gene |
13256 |
0.09 |
chr2_109904278_109904464 | 6.65 |
Platr8 |
pluripotency associated transcript 8 |
8948 |
0.18 |
chr11_115859217_115859918 | 6.58 |
Myo15b |
myosin XVB |
1161 |
0.3 |
chr7_19797273_19797480 | 6.57 |
Cblc |
Casitas B-lineage lymphoma c |
567 |
0.51 |
chr8_126497512_126498658 | 6.56 |
Gm6091 |
predicted pseudogene 6091 |
21673 |
0.18 |
chr4_131825949_131826100 | 6.55 |
Ptpru |
protein tyrosine phosphatase, receptor type, U |
4508 |
0.17 |
chr11_62756754_62757118 | 6.53 |
Zfp286 |
zinc finger protein 286 |
3621 |
0.1 |
chr11_32321243_32321420 | 6.45 |
Hbq1a |
hemoglobin, theta 1A |
21262 |
0.11 |
chr13_64248823_64249165 | 6.44 |
1810034E14Rik |
RIKEN cDNA 1810034E14 gene |
222 |
0.62 |
chr4_117210425_117210673 | 6.43 |
Gm23287 |
predicted gene, 23287 |
295 |
0.76 |
chr17_34135224_34135614 | 6.41 |
H2-DMa |
histocompatibility 2, class II, locus DMa |
209 |
0.78 |
chr15_102100432_102100913 | 6.37 |
Tns2 |
tensin 2 |
259 |
0.86 |
chr9_57259859_57260048 | 6.36 |
1700017B05Rik |
RIKEN cDNA 1700017B05 gene |
1556 |
0.34 |
chr7_141458405_141458606 | 6.32 |
Pnpla2 |
patatin-like phospholipase domain containing 2 |
1487 |
0.15 |
chr5_121215508_121215679 | 6.31 |
Hectd4 |
HECT domain E3 ubiquitin protein ligase 4 |
4626 |
0.15 |
chr2_158145791_158146607 | 6.30 |
Tgm2 |
transglutaminase 2, C polypeptide |
167 |
0.94 |
chr8_107425009_107425206 | 6.29 |
Nob1 |
NIN1/RPN12 binding protein 1 homolog |
56 |
0.96 |
chr16_5254135_5254625 | 6.28 |
Gm15983 |
predicted gene 15983 |
406 |
0.7 |
chr1_135789932_135790083 | 6.25 |
Tnni1 |
troponin I, skeletal, slow 1 |
6942 |
0.15 |
chr3_100422470_100422641 | 6.24 |
4930406D18Rik |
RIKEN cDNA 4930406D18 gene |
3850 |
0.18 |
chr7_38200605_38201261 | 6.24 |
D530033B14Rik |
RIKEN cDNA D530033B14 gene |
4476 |
0.15 |
chr10_80880416_80880588 | 6.24 |
Tmprss9 |
transmembrane protease, serine 9 |
782 |
0.4 |
chr6_90607269_90607651 | 6.23 |
Slc41a3 |
solute carrier family 41, member 3 |
2735 |
0.2 |
chr10_120202226_120202391 | 6.20 |
Irak3 |
interleukin-1 receptor-associated kinase 3 |
178 |
0.69 |
chr11_115898961_115899323 | 6.20 |
Smim5 |
small integral membrane protein 5 |
824 |
0.4 |
chr8_27058344_27058703 | 6.18 |
Plpbp |
pyridoxal phosphate binding protein |
7749 |
0.11 |
chr12_110703015_110703191 | 6.14 |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
375 |
0.79 |
chr8_83662115_83663206 | 6.12 |
Ptger1 |
prostaglandin E receptor 1 (subtype EP1) |
4018 |
0.12 |
chr11_86358219_86358558 | 6.10 |
Med13 |
mediator complex subunit 13 |
786 |
0.67 |
chr12_101028530_101029714 | 6.08 |
Ccdc88c |
coiled-coil domain containing 88C |
66 |
0.95 |
chr2_164794347_164794615 | 6.05 |
Acot8 |
acyl-CoA thioesterase 8 |
2008 |
0.13 |
chr14_69241564_69241780 | 6.04 |
Gm27222 |
predicted gene 27222 |
17474 |
0.1 |
chr11_32286850_32287048 | 6.00 |
Hbq1b |
hemoglobin, theta 1B |
16 |
0.95 |
chr7_108933988_108934499 | 5.99 |
Eif3f |
eukaryotic translation initiation factor 3, subunit F |
174 |
0.91 |
chr10_80340164_80340403 | 5.97 |
Adamtsl5 |
ADAMTS-like 5 |
198 |
0.83 |
chr4_133609845_133610022 | 5.97 |
Zdhhc18 |
zinc finger, DHHC domain containing 18 |
3101 |
0.14 |
chr8_94874399_94874675 | 5.97 |
Dok4 |
docking protein 4 |
1559 |
0.24 |
chr8_84810939_84811282 | 5.95 |
Nfix |
nuclear factor I/X |
10766 |
0.08 |
chr3_102702021_102702172 | 5.91 |
Gm42682 |
predicted gene 42682 |
12156 |
0.12 |
chr5_121842898_121843098 | 5.89 |
Sh2b3 |
SH2B adaptor protein 3 |
5352 |
0.11 |
chr8_35205759_35205935 | 5.89 |
Gm34474 |
predicted gene, 34474 |
12791 |
0.14 |
chr2_152766502_152766758 | 5.88 |
Gm23802 |
predicted gene, 23802 |
6259 |
0.12 |
chr8_107386724_107386875 | 5.87 |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
16407 |
0.14 |
chr1_135847182_135847352 | 5.86 |
Tnnt2 |
troponin T2, cardiac |
2183 |
0.22 |
chr6_91140017_91140184 | 5.81 |
Hdac11 |
histone deacetylase 11 |
16565 |
0.12 |
chr7_141363473_141363669 | 5.81 |
B230206H07Rik |
RIKEN cDNA B230206H07 gene |
1511 |
0.17 |
chr5_121606281_121606432 | 5.80 |
Acad12 |
acyl-Coenzyme A dehydrogenase family, member 12 |
727 |
0.5 |
chr4_133250719_133250884 | 5.78 |
Map3k6 |
mitogen-activated protein kinase kinase kinase 6 |
48 |
0.96 |
chr17_34912157_34912347 | 5.77 |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
1277 |
0.16 |
chr12_105025367_105025529 | 5.76 |
Gm47650 |
predicted gene, 47650 |
2515 |
0.15 |
chr11_115612426_115612788 | 5.75 |
Mif4gd |
MIF4G domain containing |
104 |
0.92 |
chr8_122551277_122551909 | 5.75 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
264 |
0.83 |
chr10_119066095_119066272 | 5.73 |
Gm33677 |
predicted gene, 33677 |
15684 |
0.14 |
chr11_58643382_58643689 | 5.73 |
Trim58 |
tripartite motif-containing 58 |
3070 |
0.1 |
chr16_93615609_93615761 | 5.73 |
Cbr1 |
carbonyl reductase 1 |
7796 |
0.12 |
chr14_54494323_54494474 | 5.72 |
Rem2 |
rad and gem related GTP binding protein 2 |
16927 |
0.08 |
chr4_132514879_132515066 | 5.72 |
Sesn2 |
sestrin 2 |
4471 |
0.11 |
chr11_72428738_72428932 | 5.71 |
Ggt6 |
gamma-glutamyltransferase 6 |
6691 |
0.13 |
chr1_180811755_180811927 | 5.70 |
H3f3a |
H3.3 histone A |
1693 |
0.2 |
chr17_71254781_71254932 | 5.70 |
Emilin2 |
elastin microfibril interfacer 2 |
550 |
0.73 |
chr3_51652342_51652542 | 5.69 |
Mgst2 |
microsomal glutathione S-transferase 2 |
7918 |
0.13 |
chr1_136175290_136175460 | 5.69 |
Kif21b |
kinesin family member 21B |
6061 |
0.12 |
chr16_17760794_17760969 | 5.63 |
Klhl22 |
kelch-like 22 |
526 |
0.61 |
chr5_149678108_149678318 | 5.62 |
B3glct |
beta-3-glucosyltransferase |
17 |
0.97 |
chr5_135013108_135013523 | 5.62 |
Abhd11os |
abhydrolase domain containing 11, opposite strand |
62 |
0.92 |
chr1_191575881_191576168 | 5.61 |
Ints7 |
integrator complex subunit 7 |
248 |
0.7 |
chr11_84918564_84918741 | 5.61 |
Znhit3 |
zinc finger, HIT type 3 |
2286 |
0.21 |
chr10_79682967_79683630 | 5.61 |
Cdc34 |
cell division cycle 34 |
772 |
0.38 |
chr17_26011828_26012086 | 5.60 |
Rab11fip3 |
RAB11 family interacting protein 3 (class II) |
6503 |
0.1 |
chr1_184771692_184771858 | 5.60 |
Gm34342 |
predicted gene, 34342 |
34798 |
0.1 |
chr6_106800000_106800478 | 5.59 |
Crbn |
cereblon |
162 |
0.96 |
chr17_56291122_56291796 | 5.58 |
Plin3 |
perilipin 3 |
948 |
0.37 |
chr11_116023790_116023980 | 5.57 |
H3f3b |
H3.3 histone B |
588 |
0.58 |
chr11_68874937_68875098 | 5.56 |
Ndel1 |
nudE neurodevelopment protein 1 like 1 |
3159 |
0.15 |
chr11_96963605_96963878 | 5.54 |
Sp2 |
Sp2 transcription factor |
4924 |
0.1 |
chr14_63066661_63066875 | 5.50 |
Defb42 |
defensin beta 42 |
11695 |
0.11 |
chr15_38473261_38474032 | 5.49 |
Mir6951 |
microRNA 6951 |
16901 |
0.13 |
chr2_28616496_28616661 | 5.48 |
Gfi1b |
growth factor independent 1B |
1173 |
0.33 |
chr19_5487823_5488173 | 5.47 |
Mus81 |
MUS81 structure-specific endonuclease subunit |
18 |
0.9 |
chr7_141671125_141671303 | 5.46 |
Muc6 |
mucin 6, gastric |
15895 |
0.13 |
chr17_27151512_27151710 | 5.46 |
Gm50316 |
predicted gene, 50316 |
12062 |
0.09 |
chr5_143424027_143424178 | 5.45 |
Gm4870 |
predicted gene 4870 |
14291 |
0.08 |
chr12_25092319_25093283 | 5.44 |
Id2 |
inhibitor of DNA binding 2 |
3286 |
0.21 |
chr1_86527639_86529135 | 5.43 |
Ptma |
prothymosin alpha |
1580 |
0.31 |
chr15_31586563_31586936 | 5.41 |
Cct5 |
chaperonin containing Tcp1, subunit 5 (epsilon) |
6312 |
0.14 |
chr7_143978749_143979219 | 5.39 |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
22944 |
0.16 |
chr1_184825191_184825423 | 5.37 |
Mtarc2 |
mitochondrial amidoxime reducing component 2 |
1950 |
0.25 |
chr14_70470301_70470544 | 5.36 |
Phyhip |
phytanoyl-CoA hydroxylase interacting protein |
11899 |
0.1 |
chr7_15930022_15930173 | 5.36 |
Selenow |
selenoprotein W |
7695 |
0.1 |
chr16_26371375_26371987 | 5.35 |
Cldn1 |
claudin 1 |
160 |
0.97 |
chr5_137107183_137107367 | 5.33 |
Trim56 |
tripartite motif-containing 56 |
8932 |
0.11 |
chr4_140763294_140763445 | 5.33 |
Padi4 |
peptidyl arginine deiminase, type IV |
1592 |
0.28 |
chr7_28972749_28972900 | 5.33 |
Eif3k |
eukaryotic translation initiation factor 3, subunit K |
2012 |
0.19 |
chr11_69887304_69887493 | 5.33 |
Acap1 |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
1019 |
0.22 |
chr9_62373844_62374002 | 5.32 |
Anp32a |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A |
484 |
0.83 |
chr3_104701048_104701250 | 5.31 |
Gm24223 |
predicted gene, 24223 |
279 |
0.83 |
chr3_96812764_96812915 | 5.30 |
Cd160 |
CD160 antigen |
1682 |
0.23 |
chr11_113648266_113648463 | 5.29 |
Cog1 |
component of oligomeric golgi complex 1 |
805 |
0.48 |
chr4_149307680_149308484 | 5.26 |
Kif1b |
kinesin family member 1B |
389 |
0.8 |
chr4_106803896_106804054 | 5.24 |
Acot11 |
acyl-CoA thioesterase 11 |
1023 |
0.5 |
chr10_43479277_43480054 | 5.22 |
Bend3 |
BEN domain containing 3 |
525 |
0.71 |
chr3_137991268_137991451 | 5.21 |
Gm19708 |
predicted gene, 19708 |
9580 |
0.13 |
chr15_100468581_100468824 | 5.19 |
5330439K02Rik |
RIKEN cDNA 5330439K02 gene |
11 |
0.82 |
chr15_73755237_73755442 | 5.19 |
Ptp4a3 |
protein tyrosine phosphatase 4a3 |
6965 |
0.17 |
chr19_5094164_5095202 | 5.18 |
Cnih2 |
cornichon family AMPA receptor auxiliary protein 2 |
3699 |
0.08 |
chr5_123149727_123149944 | 5.18 |
Setd1b |
SET domain containing 1B |
6878 |
0.08 |
chr5_122104350_122104501 | 5.17 |
Myl2 |
myosin, light polypeptide 2, regulatory, cardiac, slow |
512 |
0.72 |
chr2_173038101_173038586 | 5.17 |
Gm14453 |
predicted gene 14453 |
3763 |
0.17 |
chr6_47835391_47836477 | 5.17 |
Zfp398 |
zinc finger protein 398 |
239 |
0.86 |
chr5_143066530_143067001 | 5.17 |
Gm43380 |
predicted gene 43380 |
888 |
0.5 |
chr4_140700990_140701441 | 5.15 |
Rcc2 |
regulator of chromosome condensation 2 |
258 |
0.87 |
chr8_119927825_119927991 | 5.14 |
Usp10 |
ubiquitin specific peptidase 10 |
9774 |
0.16 |
chr1_180976442_180976593 | 5.14 |
Gm36961 |
predicted gene, 36961 |
228 |
0.86 |
chr11_103158624_103159304 | 5.13 |
Fmnl1 |
formin-like 1 |
12143 |
0.11 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 14.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
2.6 | 10.6 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
2.6 | 10.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
2.4 | 7.1 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
2.2 | 6.6 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
2.2 | 6.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
2.0 | 10.0 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
2.0 | 5.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
2.0 | 5.9 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
1.9 | 11.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.8 | 5.5 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
1.7 | 8.7 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
1.7 | 5.2 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
1.6 | 4.8 | GO:0002432 | granuloma formation(GO:0002432) |
1.5 | 4.6 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
1.5 | 6.0 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.5 | 6.0 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.5 | 3.0 | GO:0036394 | amylase secretion(GO:0036394) |
1.5 | 7.3 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
1.4 | 4.2 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
1.4 | 4.2 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.4 | 4.1 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
1.4 | 5.4 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.3 | 4.0 | GO:0006203 | dGTP catabolic process(GO:0006203) |
1.3 | 6.5 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
1.3 | 5.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
1.3 | 3.8 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.3 | 5.0 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
1.2 | 1.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
1.2 | 4.8 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.2 | 3.5 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
1.2 | 2.3 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
1.2 | 5.8 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
1.2 | 3.5 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.1 | 4.6 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
1.1 | 5.7 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
1.1 | 2.2 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
1.1 | 3.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.1 | 3.3 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
1.1 | 5.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
1.1 | 3.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.1 | 2.1 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
1.1 | 4.3 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
1.1 | 1.1 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
1.1 | 8.5 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
1.1 | 5.3 | GO:2001225 | regulation of chloride transport(GO:2001225) |
1.1 | 2.1 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
1.1 | 6.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
1.0 | 3.1 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
1.0 | 5.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
1.0 | 3.0 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.0 | 4.0 | GO:0021590 | cerebellum maturation(GO:0021590) |
1.0 | 1.0 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
1.0 | 2.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
1.0 | 2.9 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
1.0 | 2.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.0 | 4.8 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.9 | 2.8 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.9 | 4.7 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.9 | 4.7 | GO:0015886 | heme transport(GO:0015886) |
0.9 | 3.7 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.9 | 4.6 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.9 | 3.7 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.9 | 5.5 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.9 | 2.7 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.9 | 0.9 | GO:0051775 | response to redox state(GO:0051775) |
0.9 | 1.8 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.9 | 2.7 | GO:0032439 | endosome localization(GO:0032439) |
0.9 | 0.9 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.9 | 4.4 | GO:0018101 | protein citrullination(GO:0018101) |
0.9 | 2.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.9 | 7.0 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.9 | 0.9 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.9 | 7.0 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.9 | 0.9 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.9 | 4.3 | GO:0071910 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
0.9 | 3.5 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.9 | 1.7 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.9 | 4.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.9 | 2.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.9 | 3.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.9 | 8.6 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.9 | 5.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.9 | 6.8 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.8 | 2.5 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.8 | 5.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.8 | 2.5 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.8 | 2.5 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.8 | 2.5 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.8 | 1.6 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.8 | 5.7 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.8 | 3.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.8 | 6.4 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.8 | 4.0 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.8 | 4.8 | GO:0051639 | actin filament network formation(GO:0051639) |
0.8 | 2.4 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.8 | 2.4 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.8 | 2.4 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.8 | 7.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.8 | 0.8 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.8 | 3.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.8 | 3.9 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.8 | 7.0 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.8 | 0.8 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.8 | 6.2 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.8 | 3.1 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.8 | 5.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.8 | 3.9 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.8 | 2.3 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.8 | 0.8 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.8 | 0.8 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.8 | 3.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.8 | 2.3 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.8 | 2.3 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.8 | 2.3 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.8 | 3.0 | GO:0007418 | ventral midline development(GO:0007418) |
0.8 | 2.3 | GO:0019230 | proprioception(GO:0019230) |
0.8 | 3.8 | GO:0072553 | terminal button organization(GO:0072553) |
0.8 | 3.0 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.8 | 5.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.8 | 3.0 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.8 | 25.6 | GO:0033141 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.7 | 2.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.7 | 2.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.7 | 7.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.7 | 1.4 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.7 | 6.4 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.7 | 2.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.7 | 1.4 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.7 | 4.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.7 | 4.2 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.7 | 0.7 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.7 | 0.7 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.7 | 3.5 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.7 | 3.5 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.7 | 2.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.7 | 3.4 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.7 | 1.4 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.7 | 2.0 | GO:0009223 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.7 | 2.0 | GO:0015793 | glycerol transport(GO:0015793) |
0.7 | 4.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.7 | 2.7 | GO:0051031 | tRNA transport(GO:0051031) |
0.7 | 2.7 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.7 | 0.7 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.7 | 2.7 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.7 | 0.7 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.7 | 2.7 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.7 | 4.6 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.7 | 6.6 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.7 | 1.3 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.7 | 2.0 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.6 | 1.3 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.6 | 1.9 | GO:0033483 | gas homeostasis(GO:0033483) |
0.6 | 2.6 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.6 | 5.2 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.6 | 9.6 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.6 | 3.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.6 | 14.7 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.6 | 2.5 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.6 | 5.7 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.6 | 1.3 | GO:0003166 | bundle of His development(GO:0003166) |
0.6 | 2.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.6 | 0.6 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.6 | 3.2 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.6 | 1.3 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.6 | 3.8 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.6 | 1.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.6 | 3.1 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.6 | 2.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.6 | 1.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.6 | 2.5 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.6 | 1.9 | GO:0060416 | response to growth hormone(GO:0060416) |
0.6 | 2.5 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.6 | 3.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.6 | 2.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.6 | 2.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.6 | 1.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.6 | 1.2 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.6 | 1.8 | GO:0007000 | nucleolus organization(GO:0007000) |
0.6 | 6.1 | GO:0018904 | ether metabolic process(GO:0018904) |
0.6 | 1.8 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.6 | 1.8 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.6 | 1.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.6 | 0.6 | GO:0052248 | modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) |
0.6 | 3.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.6 | 3.0 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.6 | 0.6 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.6 | 4.1 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.6 | 1.8 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.6 | 0.6 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.6 | 6.5 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.6 | 1.8 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.6 | 1.2 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.6 | 1.7 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.6 | 1.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.6 | 3.5 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.6 | 1.7 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.6 | 2.9 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.6 | 1.7 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.6 | 2.9 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.6 | 1.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.6 | 6.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.6 | 1.1 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.6 | 4.5 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.6 | 1.7 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.6 | 0.6 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.6 | 7.9 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.6 | 1.1 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.6 | 1.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.6 | 2.8 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.6 | 1.7 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.6 | 3.9 | GO:0060056 | mammary gland involution(GO:0060056) |
0.6 | 0.6 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.6 | 1.7 | GO:0002254 | kinin cascade(GO:0002254) |
0.5 | 1.6 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.5 | 1.1 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.5 | 8.8 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.5 | 2.2 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.5 | 2.2 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.5 | 1.6 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.5 | 2.2 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.5 | 1.1 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.5 | 0.5 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.5 | 1.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.5 | 1.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.5 | 1.1 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.5 | 1.6 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.5 | 1.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.5 | 1.6 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.5 | 1.6 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.5 | 1.6 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.5 | 0.5 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.5 | 4.3 | GO:0034204 | lipid translocation(GO:0034204) |
0.5 | 1.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.5 | 1.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.5 | 1.1 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.5 | 1.6 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.5 | 4.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.5 | 1.6 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.5 | 2.1 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.5 | 1.0 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.5 | 4.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.5 | 3.1 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.5 | 8.3 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.5 | 1.5 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.5 | 2.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.5 | 1.5 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.5 | 2.0 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.5 | 2.5 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.5 | 7.1 | GO:0043486 | histone exchange(GO:0043486) |
0.5 | 1.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.5 | 2.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.5 | 3.0 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.5 | 2.0 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.5 | 1.0 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.5 | 4.0 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.5 | 1.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.5 | 2.0 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.5 | 3.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.5 | 1.5 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.5 | 6.4 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.5 | 1.0 | GO:0044351 | macropinocytosis(GO:0044351) |
0.5 | 1.9 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.5 | 1.0 | GO:0036166 | phenotypic switching(GO:0036166) |
0.5 | 1.4 | GO:0071865 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.5 | 5.3 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.5 | 1.4 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.5 | 1.4 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.5 | 12.8 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.5 | 0.5 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.5 | 1.9 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.5 | 1.4 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.5 | 1.4 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.5 | 1.4 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.5 | 1.9 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.5 | 0.5 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.5 | 1.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.5 | 1.4 | GO:0014842 | skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.5 | 0.9 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.5 | 1.4 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.5 | 5.6 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.5 | 0.5 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.5 | 1.4 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.5 | 4.6 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.5 | 1.8 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.5 | 0.9 | GO:1902075 | cellular response to salt(GO:1902075) |
0.5 | 7.3 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.5 | 0.9 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.5 | 3.6 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.5 | 2.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.5 | 3.2 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.5 | 1.4 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.4 | 4.0 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
0.4 | 1.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.4 | 5.8 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.4 | 1.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.4 | 0.9 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.4 | 1.3 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.4 | 1.3 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.4 | 0.9 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.4 | 1.3 | GO:1902109 | negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.4 | 0.9 | GO:0006868 | glutamine transport(GO:0006868) |
0.4 | 5.3 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.4 | 3.9 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.4 | 3.9 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.4 | 2.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.4 | 4.7 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.4 | 0.9 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.4 | 2.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.4 | 0.4 | GO:0003179 | heart valve morphogenesis(GO:0003179) |
0.4 | 2.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.4 | 0.8 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.4 | 0.4 | GO:0070141 | response to UV-A(GO:0070141) |
0.4 | 1.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.4 | 1.3 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.4 | 1.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.4 | 0.4 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.4 | 0.4 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.4 | 1.7 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.4 | 1.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.4 | 3.4 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.4 | 5.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.4 | 1.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.4 | 0.8 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 2.5 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.4 | 2.9 | GO:0030033 | microvillus assembly(GO:0030033) |
0.4 | 1.2 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.4 | 2.1 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.4 | 5.4 | GO:0016180 | snRNA processing(GO:0016180) |
0.4 | 0.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.4 | 2.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 1.2 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.4 | 0.8 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.4 | 0.4 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.4 | 0.4 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.4 | 4.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.4 | 6.9 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.4 | 5.7 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.4 | 4.1 | GO:0014850 | response to muscle activity(GO:0014850) |
0.4 | 0.4 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.4 | 1.6 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.4 | 1.6 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.4 | 2.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.4 | 1.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.4 | 2.8 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.4 | 1.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.4 | 1.6 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.4 | 1.6 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.4 | 1.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.4 | 2.8 | GO:0002467 | germinal center formation(GO:0002467) |
0.4 | 2.8 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) |
0.4 | 3.6 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.4 | 2.8 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.4 | 2.4 | GO:0002934 | desmosome organization(GO:0002934) |
0.4 | 1.6 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.4 | 1.6 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.4 | 0.4 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.4 | 4.7 | GO:0071451 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.4 | 0.8 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.4 | 1.6 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.4 | 1.2 | GO:0000087 | mitotic M phase(GO:0000087) |
0.4 | 1.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.4 | 0.8 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.4 | 8.9 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.4 | 7.4 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.4 | 8.9 | GO:0031648 | protein destabilization(GO:0031648) |
0.4 | 1.5 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.4 | 1.9 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.4 | 1.5 | GO:0003383 | apical constriction(GO:0003383) |
0.4 | 1.1 | GO:0009180 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.4 | 1.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.4 | 1.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.4 | 1.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.4 | 1.5 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.4 | 0.8 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.4 | 2.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 4.9 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.4 | 2.3 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.4 | 1.5 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.4 | 0.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.4 | 2.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.4 | 0.4 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.4 | 1.1 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.4 | 3.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.4 | 3.0 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.4 | 0.7 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.4 | 1.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.4 | 0.4 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.4 | 1.1 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.4 | 8.5 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.4 | 0.4 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.4 | 1.5 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.4 | 2.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.4 | 0.7 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.4 | 3.7 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.4 | 0.7 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.4 | 1.1 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.4 | 1.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.4 | 0.7 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.4 | 1.1 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.4 | 1.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.4 | 1.1 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.4 | 5.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.4 | 1.5 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.4 | 1.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.4 | 2.9 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.4 | 1.1 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.4 | 1.1 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.4 | 7.6 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.4 | 3.3 | GO:0046697 | decidualization(GO:0046697) |
0.4 | 0.4 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.4 | 4.0 | GO:0006833 | water transport(GO:0006833) |
0.4 | 1.1 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.4 | 0.7 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.4 | 3.5 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.4 | 5.7 | GO:0009303 | rRNA transcription(GO:0009303) |
0.4 | 1.8 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.4 | 0.4 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.4 | 1.1 | GO:0006903 | vesicle targeting(GO:0006903) |
0.4 | 1.8 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.4 | 0.4 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.4 | 1.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.3 | 2.8 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.3 | 0.7 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.3 | 1.4 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.3 | 0.3 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.3 | 1.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.3 | 1.0 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.3 | 1.0 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.3 | 0.3 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.3 | 0.7 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.3 | 1.4 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.3 | 0.3 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.3 | 0.3 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.3 | 1.0 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.3 | 6.2 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.3 | 2.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.3 | 0.7 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.3 | 3.1 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.3 | 4.1 | GO:0042407 | cristae formation(GO:0042407) |
0.3 | 0.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.3 | 1.4 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.3 | 0.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.3 | 1.7 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.3 | 0.7 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) |
0.3 | 0.3 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.3 | 2.0 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.3 | 1.3 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.3 | 2.0 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
0.3 | 8.7 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.3 | 1.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.3 | 0.3 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.3 | 1.0 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.3 | 4.3 | GO:0070266 | necroptotic process(GO:0070266) |
0.3 | 0.7 | GO:0003170 | heart valve development(GO:0003170) |
0.3 | 0.7 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.3 | 0.7 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.3 | 2.0 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.3 | 1.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.3 | 0.7 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.3 | 0.6 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.3 | 0.3 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.3 | 0.6 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.3 | 1.3 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.3 | 1.3 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.3 | 3.2 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.3 | 2.9 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.3 | 0.3 | GO:0048370 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.3 | 0.6 | GO:0000303 | response to superoxide(GO:0000303) |
0.3 | 0.6 | GO:0033762 | response to glucagon(GO:0033762) |
0.3 | 1.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.3 | 0.3 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.3 | 2.9 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.3 | 0.6 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.3 | 1.0 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 1.0 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.3 | 0.6 | GO:0035973 | aggrephagy(GO:0035973) |
0.3 | 0.6 | GO:0035928 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) rRNA transport(GO:0051029) |
0.3 | 0.3 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.3 | 0.3 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.3 | 0.3 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.3 | 0.3 | GO:0002576 | platelet degranulation(GO:0002576) |
0.3 | 2.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.3 | 0.6 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.3 | 7.1 | GO:0045841 | negative regulation of mitotic sister chromatid segregation(GO:0033048) negative regulation of mitotic metaphase/anaphase transition(GO:0045841) mitotic spindle checkpoint(GO:0071174) negative regulation of metaphase/anaphase transition of cell cycle(GO:1902100) negative regulation of mitotic sister chromatid separation(GO:2000816) |
0.3 | 1.6 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.3 | 0.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 0.3 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.3 | 0.6 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.3 | 4.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.3 | 0.6 | GO:0006562 | proline catabolic process(GO:0006562) |
0.3 | 0.9 | GO:0097421 | liver regeneration(GO:0097421) |
0.3 | 0.6 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.3 | 0.6 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.3 | 3.1 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.3 | 1.2 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.3 | 0.9 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.3 | 1.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.3 | 0.3 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.3 | 3.7 | GO:0015858 | nucleoside transport(GO:0015858) |
0.3 | 0.6 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.3 | 6.4 | GO:0016575 | histone deacetylation(GO:0016575) |
0.3 | 0.6 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.3 | 0.6 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.3 | 1.8 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.3 | 0.3 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.3 | 1.5 | GO:0014823 | response to activity(GO:0014823) |
0.3 | 0.3 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.3 | 3.6 | GO:0031167 | rRNA methylation(GO:0031167) |
0.3 | 0.6 | GO:0010042 | response to manganese ion(GO:0010042) |
0.3 | 8.1 | GO:0007032 | endosome organization(GO:0007032) |
0.3 | 0.9 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.3 | 1.2 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.3 | 0.3 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) positive regulation of histone H4 acetylation(GO:0090240) |
0.3 | 2.7 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.3 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.3 | 1.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.3 | 1.5 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.3 | 1.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 1.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 0.3 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.3 | 1.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.3 | 0.3 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.3 | 0.9 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.3 | 3.6 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.3 | 4.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.3 | 8.0 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.3 | 0.3 | GO:0097374 | sensory neuron axon guidance(GO:0097374) dorsal root ganglion development(GO:1990791) |
0.3 | 1.8 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.3 | 0.3 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.3 | 1.2 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.3 | 3.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.3 | 0.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.3 | 0.9 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.3 | 0.6 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.3 | 2.6 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.3 | 3.2 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.3 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 0.6 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.3 | 0.9 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.3 | 2.0 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.3 | 0.9 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.3 | 0.6 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.3 | 4.1 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.3 | 0.3 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.3 | 1.5 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.3 | 2.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.3 | 1.5 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.3 | 0.9 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 1.7 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.3 | 0.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.3 | 0.3 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.3 | 4.0 | GO:0033273 | response to vitamin(GO:0033273) |
0.3 | 0.9 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.3 | 0.3 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.3 | 2.6 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.3 | 0.3 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.3 | 0.3 | GO:0002339 | B cell selection(GO:0002339) |
0.3 | 2.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 0.3 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.3 | 0.3 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.3 | 1.4 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.3 | 0.6 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.3 | 0.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.3 | 2.5 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.3 | 2.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.3 | 4.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.3 | 0.5 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.3 | 0.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 1.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.3 | 0.8 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.3 | 0.8 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.3 | 4.9 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.3 | 1.6 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.3 | 0.3 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.3 | 0.3 | GO:0009650 | UV protection(GO:0009650) |
0.3 | 4.3 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.3 | 0.5 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.3 | 1.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 0.8 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.3 | 0.5 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.3 | 1.6 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.3 | 0.3 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.3 | 2.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.3 | 0.5 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.3 | 1.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 0.8 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.3 | 0.3 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.3 | 0.8 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.3 | 1.3 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
0.3 | 0.5 | GO:1990144 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.3 | 0.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.3 | 0.3 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.3 | 0.5 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
0.3 | 0.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 0.5 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 0.8 | GO:0015871 | choline transport(GO:0015871) |
0.3 | 1.3 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.3 | 2.4 | GO:0097320 | membrane tubulation(GO:0097320) |
0.3 | 1.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 1.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 0.5 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.3 | 1.8 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.3 | 0.8 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.3 | 3.6 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.3 | 0.8 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.3 | 1.3 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.3 | 0.3 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.3 | 0.5 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.3 | 0.3 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.3 | 1.3 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.3 | 0.8 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.3 | 1.0 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.3 | 0.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.3 | 0.8 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.3 | 0.3 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.3 | 0.3 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.3 | 2.8 | GO:0046463 | triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.3 | 0.5 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.3 | 0.5 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.3 | 0.5 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.3 | 1.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.3 | 0.3 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.3 | 1.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.3 | 0.5 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.3 | 0.3 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.3 | 0.8 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.3 | 1.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.3 | 2.5 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.3 | 2.5 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.3 | 0.5 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.3 | 1.0 | GO:0043297 | apical junction assembly(GO:0043297) |
0.3 | 0.3 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.3 | 1.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.3 | 0.5 | GO:0042033 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) |
0.2 | 0.7 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.2 | 0.2 | GO:0043482 | cellular pigment accumulation(GO:0043482) |
0.2 | 0.2 | GO:2000468 | neutrophil aggregation(GO:0070488) regulation of peroxidase activity(GO:2000468) |
0.2 | 0.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 1.0 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.2 | 1.2 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.2 | 0.5 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 0.7 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.2 | 0.2 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.2 | 0.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.5 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.2 | 0.5 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.2 | 1.0 | GO:0015671 | oxygen transport(GO:0015671) |
0.2 | 2.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.2 | 0.5 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 0.5 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.2 | 0.2 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.2 | 1.5 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.2 | 0.2 | GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.2 | 0.7 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.2 | 1.2 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.2 | 1.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.2 | 0.5 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.2 | 3.1 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.7 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.2 | 0.5 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 0.5 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.2 | 0.7 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.2 | 0.7 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.2 | 2.6 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.2 | 1.9 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 7.0 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 0.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 1.7 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.2 | 0.2 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.2 | 0.5 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.7 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.2 | 0.9 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 1.9 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 2.8 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 0.7 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 0.7 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 6.2 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.2 | 0.7 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.2 | 0.9 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.2 | 0.9 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.2 | 0.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 0.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.2 | GO:0001945 | lymph vessel development(GO:0001945) |
0.2 | 0.7 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.2 | 0.7 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 0.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.9 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.2 | 0.2 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.2 | 4.1 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.2 | 1.4 | GO:0002076 | osteoblast development(GO:0002076) |
0.2 | 1.8 | GO:0071357 | cellular response to type I interferon(GO:0071357) |
0.2 | 0.2 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.2 | 0.5 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 1.4 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.2 | 0.9 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.5 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.2 | 1.6 | GO:0031639 | plasminogen activation(GO:0031639) |
0.2 | 0.2 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.2 | 4.7 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.2 | 0.7 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.2 | 1.4 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.2 | 0.7 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.2 | 1.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.2 | 0.7 | GO:0009838 | abscission(GO:0009838) |
0.2 | 0.2 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 1.1 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.2 | 0.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 2.9 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.2 | 0.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.2 | 0.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.2 | 1.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 1.3 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.2 | 0.9 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.2 | 0.7 | GO:0000237 | leptotene(GO:0000237) |
0.2 | 4.9 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.2 | 2.6 | GO:0048821 | erythrocyte development(GO:0048821) |
0.2 | 1.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.2 | 0.4 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.2 | 0.7 | GO:0090009 | primitive streak formation(GO:0090009) |
0.2 | 1.5 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.2 | 1.5 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.2 | 0.4 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 1.3 | GO:0050779 | RNA destabilization(GO:0050779) |
0.2 | 1.5 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.2 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.2 | 0.7 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 0.4 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.2 | 0.7 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.2 | 1.1 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.2 | 1.3 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.2 | 1.1 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 1.5 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.2 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 0.2 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.2 | 1.5 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.2 | 1.9 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.9 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 1.9 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 0.6 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 0.4 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.2 | 1.3 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.2 | 2.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 1.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 0.6 | GO:0060065 | uterus development(GO:0060065) |
0.2 | 0.4 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 0.2 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 0.4 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 0.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.2 | 0.2 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.2 | 0.2 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.2 | 2.7 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.2 | 0.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 0.8 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.2 | 0.4 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.2 | 0.8 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.2 | 0.6 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 0.2 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.2 | 0.6 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.2 | 0.4 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
0.2 | 1.0 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.2 | 0.4 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.2 | 0.8 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.2 | 2.1 | GO:0007614 | short-term memory(GO:0007614) |
0.2 | 1.2 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 0.2 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.2 | 0.8 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 1.0 | GO:0051026 | chiasma assembly(GO:0051026) |
0.2 | 0.8 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.4 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 | 3.0 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.2 | 0.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.2 | 1.4 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 0.4 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.2 | 0.2 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.2 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 1.4 | GO:0006560 | proline metabolic process(GO:0006560) |
0.2 | 2.2 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 0.6 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.2 | 2.4 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 0.6 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.2 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.2 | 0.6 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.2 | 2.6 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.2 | 1.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 1.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 0.2 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.2 | 3.8 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.2 | 0.6 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.2 | 15.8 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.2 | 1.6 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.2 | 0.6 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 0.4 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 5.7 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.2 | 0.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.2 | 0.6 | GO:0033572 | transferrin transport(GO:0033572) |
0.2 | 0.2 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 0.6 | GO:0043921 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.2 | 0.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.2 | 0.8 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.2 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.2 | 4.3 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.2 | 0.4 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.2 | 0.8 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.4 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.2 | 1.0 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 1.7 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.2 | 1.0 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 0.8 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.2 | 0.2 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.2 | 1.0 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 0.6 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.6 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 0.8 | GO:0010225 | response to UV-C(GO:0010225) |
0.2 | 0.4 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.2 | 0.4 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.2 | 0.6 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.2 | 1.5 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.2 | 0.9 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.2 | 0.8 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
0.2 | 0.9 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.2 | 0.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 0.8 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.2 | 0.4 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.2 | 0.4 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 1.3 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.2 | 0.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.9 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.2 | 0.7 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.2 | 0.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 5.4 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.2 | 0.6 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.2 | 0.2 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.2 | 0.9 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.2 | 0.6 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 2.2 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.2 | 0.2 | GO:0030325 | adrenal gland development(GO:0030325) |
0.2 | 1.3 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.2 | 0.2 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 0.6 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.6 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 1.5 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.9 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 0.7 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.2 | 0.9 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.2 | 1.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.4 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.2 | 0.9 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 1.6 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
0.2 | 0.4 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.2 | 1.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 0.4 | GO:0070305 | response to cGMP(GO:0070305) |
0.2 | 0.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 0.5 | GO:0001893 | maternal placenta development(GO:0001893) |
0.2 | 1.6 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.2 | 0.4 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.2 | 1.6 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.2 | 0.7 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.2 | 1.6 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 0.5 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.2 | 0.2 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.2 | 1.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 0.5 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.2 | 0.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 0.4 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.2 | 1.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 0.4 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.2 | 0.2 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.2 | 0.7 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.2 | 1.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.9 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.2 | 0.9 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.2 | 0.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 0.5 | GO:0042904 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) terpenoid biosynthetic process(GO:0016114) 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 1.0 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.2 | 0.5 | GO:0009299 | mRNA transcription(GO:0009299) |
0.2 | 0.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 1.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.2 | 0.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.3 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.2 | 0.5 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 0.9 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.2 | 0.2 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
0.2 | 0.2 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.2 | 0.5 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.2 | 0.3 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.2 | 0.3 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) negative regulation of lymphangiogenesis(GO:1901491) |
0.2 | 0.2 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.2 | 0.5 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.2 | 0.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 0.2 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.2 | 0.5 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.2 | 3.9 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.2 | 2.5 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 1.0 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.2 | 1.2 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.2 | 0.3 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
0.2 | 0.8 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.2 | 0.3 | GO:0042730 | fibrinolysis(GO:0042730) |
0.2 | 0.3 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.2 | 0.3 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.2 | 0.2 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.2 | 0.3 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.2 | 0.5 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 1.1 | GO:0046479 | glycosphingolipid catabolic process(GO:0046479) |
0.2 | 0.2 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.2 | 0.5 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.2 | 1.5 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.2 | 0.3 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.2 | 0.5 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.2 | 0.5 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 0.3 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.2 | 0.5 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.2 | 1.0 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.2 | 1.4 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.2 | 0.8 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.2 | 0.2 | GO:0061511 | centriole elongation(GO:0061511) |
0.2 | 0.3 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 6.2 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.2 | 0.3 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.2 | 0.2 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.2 | 1.9 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.2 | 0.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.2 | 1.4 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.2 | 1.0 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 0.3 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 0.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.2 | 0.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 0.5 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.2 | 0.2 | GO:0043558 | regulation of translational initiation in response to stress(GO:0043558) |
0.2 | 0.5 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.2 | 0.3 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 0.5 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.2 | 1.6 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.2 | 1.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.2 | 1.6 | GO:0007088 | regulation of mitotic nuclear division(GO:0007088) |
0.2 | 0.5 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 1.9 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.2 | 0.2 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.2 | 0.5 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.2 | 0.2 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.2 | 2.3 | GO:0046916 | cellular transition metal ion homeostasis(GO:0046916) |
0.2 | 2.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 0.2 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.2 | 0.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 0.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 1.5 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.2 | 0.5 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) positive regulation of early endosome to late endosome transport(GO:2000643) |
0.2 | 0.8 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 1.1 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.2 | 2.6 | GO:0015914 | phospholipid transport(GO:0015914) |
0.2 | 0.8 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.5 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.2 | 1.1 | GO:0032392 | DNA geometric change(GO:0032392) |
0.2 | 0.5 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.2 | 0.2 | GO:0044766 | multi-organism transport(GO:0044766) multi-organism localization(GO:1902579) |
0.2 | 0.3 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.2 | 0.6 | GO:0036233 | glycine import(GO:0036233) |
0.2 | 1.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.2 | 0.5 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.2 | 0.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 2.6 | GO:0032109 | positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.2 | 0.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.6 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 0.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 1.3 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.6 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 2.5 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.4 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.1 | 0.3 | GO:0033047 | regulation of mitotic sister chromatid segregation(GO:0033047) |
0.1 | 0.1 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 1.2 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 1.8 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 1.0 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 0.3 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 7.3 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 0.7 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.1 | 0.1 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 4.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 11.2 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.4 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.4 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 3.9 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.1 | 0.1 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 1.7 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 0.6 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 0.1 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.1 | 0.7 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 7.4 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 2.3 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.1 | 0.3 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.3 | GO:0009110 | vitamin biosynthetic process(GO:0009110) |
0.1 | 4.1 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.6 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.3 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.1 | 0.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.3 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 1.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.3 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
0.1 | 0.7 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 14.0 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 0.7 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.1 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.3 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.1 | 2.3 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.4 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 0.7 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.1 | 0.4 | GO:0036514 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.1 | 0.3 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.1 | 0.3 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 0.5 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 2.9 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.8 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.3 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.1 | 0.5 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 0.5 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.8 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.7 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 0.3 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.1 | 1.3 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 0.4 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 7.2 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 0.3 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.1 | 1.2 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.3 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.3 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.1 | 0.1 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.1 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.1 | 0.1 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.1 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.3 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 1.7 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.5 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.3 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.3 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.4 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.1 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.6 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.1 | 0.4 | GO:1900101 | regulation of endoplasmic reticulum unfolded protein response(GO:1900101) |
0.1 | 1.5 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.1 | 0.8 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 3.4 | GO:0051321 | meiotic cell cycle(GO:0051321) |
0.1 | 0.6 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.4 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.1 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.5 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.1 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.1 | 0.6 | GO:0006949 | syncytium formation(GO:0006949) |
0.1 | 0.1 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.1 | 0.4 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 0.1 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.5 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.7 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.1 | 0.5 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.1 | 1.7 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.1 | 1.2 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.1 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.1 | 0.5 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.4 | GO:0036035 | osteoclast development(GO:0036035) |
0.1 | 2.7 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 0.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.1 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.1 | 0.1 | GO:0032898 | neurotrophin production(GO:0032898) |
0.1 | 0.4 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 0.4 | GO:0003203 | endocardial cushion morphogenesis(GO:0003203) |
0.1 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 1.4 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.1 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.1 | 0.4 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 0.5 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 1.3 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) |
0.1 | 0.7 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.8 | GO:0032402 | establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) |
0.1 | 0.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 2.4 | GO:0071466 | cellular response to xenobiotic stimulus(GO:0071466) |
0.1 | 0.2 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.1 | 0.1 | GO:0060026 | convergent extension(GO:0060026) |
0.1 | 0.1 | GO:0071726 | response to diacyl bacterial lipopeptide(GO:0071724) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to diacyl bacterial lipopeptide(GO:0071726) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.1 | 0.2 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.9 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.7 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.3 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.8 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.1 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.2 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.1 | 0.9 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.1 | 0.2 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.1 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.5 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.3 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.2 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.1 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.2 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 1.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 3.1 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.1 | 0.4 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.1 | 0.2 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 0.8 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.2 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.1 | 0.1 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.1 | 0.3 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.1 | 0.1 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.1 | 0.1 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.1 | 2.1 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.3 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.5 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.1 | 0.9 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.5 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 1.7 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 1.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.1 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.1 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.1 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.1 | 0.5 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 0.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.1 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.1 | 0.5 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.1 | 0.2 | GO:0032094 | response to food(GO:0032094) |
0.1 | 2.2 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 0.4 | GO:0042255 | ribosome assembly(GO:0042255) |
0.1 | 0.6 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 0.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.2 | GO:0030320 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
0.1 | 1.2 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.7 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.1 | 0.2 | GO:0090559 | regulation of membrane permeability(GO:0090559) |
0.1 | 0.4 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.1 | 0.3 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 1.2 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.1 | 1.3 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 1.2 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.1 | 1.2 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 1.0 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.2 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.9 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.9 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.1 | 0.3 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.1 | 0.2 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 1.1 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.1 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 0.6 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.1 | 0.1 | GO:1905038 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) |
0.1 | 0.2 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.6 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.1 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.1 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 0.1 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.1 | 0.4 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.7 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.1 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
0.1 | 0.6 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.3 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 2.3 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.4 | GO:0030501 | positive regulation of bone mineralization(GO:0030501) |
0.1 | 0.5 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.7 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
0.1 | 0.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.1 | GO:0034165 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.3 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 1.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.1 | GO:0033363 | secretory granule organization(GO:0033363) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 2.6 | GO:0009988 | cell-cell recognition(GO:0009988) |
0.1 | 2.9 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.1 | 0.1 | GO:1903273 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
0.1 | 1.7 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
0.1 | 0.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 1.1 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 0.8 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.6 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.1 | 1.3 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.4 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 0.2 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.1 | 0.2 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.2 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.1 | 1.9 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 1.1 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.1 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 2.0 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.1 | 1.0 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 3.8 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.3 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 0.1 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.1 | 0.2 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.1 | 0.1 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.1 | 1.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.4 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.1 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
0.1 | 1.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.3 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.1 | GO:0070265 | necrotic cell death(GO:0070265) |
0.1 | 0.6 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.1 | 0.3 | GO:0070344 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.1 | 0.1 | GO:0045979 | positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of ATP metabolic process(GO:1903580) |
0.1 | 0.2 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.1 | 0.3 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 0.4 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 0.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 1.3 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 1.7 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 0.1 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 0.2 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.1 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.1 | 0.1 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.1 | 0.2 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.1 | 0.3 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
0.1 | 0.4 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 | 0.6 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.7 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.1 | 0.9 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.5 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.2 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.2 | GO:0010665 | regulation of cardiac muscle cell apoptotic process(GO:0010665) |
0.1 | 1.9 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.5 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.1 | 0.1 | GO:1990748 | cellular detoxification(GO:1990748) |
0.1 | 0.6 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.4 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.1 | 0.1 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.1 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 1.5 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.2 | GO:0090399 | replicative senescence(GO:0090399) |
0.1 | 0.3 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.1 | 0.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 0.4 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.1 | 0.3 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.8 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.1 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.1 | 0.4 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.1 | 0.2 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.1 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.1 | 0.7 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.4 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.8 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.6 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.1 | 0.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 1.4 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.1 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.1 | 0.2 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 3.7 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.1 | 0.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 2.0 | GO:0009408 | response to heat(GO:0009408) |
0.1 | 0.1 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.1 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.4 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.1 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.1 | 0.1 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.1 | 0.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.6 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.1 | 0.4 | GO:0009409 | response to cold(GO:0009409) |
0.1 | 0.1 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.1 | 0.1 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 0.5 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.1 | 0.3 | GO:0002385 | mucosal immune response(GO:0002385) |
0.1 | 0.2 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 0.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 1.0 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 0.6 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.1 | 0.6 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.1 | 0.2 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.2 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.1 | 0.3 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.1 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.5 | GO:1901184 | regulation of ERBB signaling pathway(GO:1901184) |
0.1 | 0.1 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 0.2 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 0.2 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.1 | 0.1 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.2 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.5 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.1 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 1.0 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.2 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.1 | 0.1 | GO:2000345 | regulation of hepatocyte proliferation(GO:2000345) |
0.1 | 0.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 3.0 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.1 | 0.1 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
0.1 | 2.8 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.4 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.1 | GO:0044126 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.1 | 0.1 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 0.1 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.1 | 1.0 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.2 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.2 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.3 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.2 | GO:0042438 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.1 | 0.1 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.1 | 0.6 | GO:0034620 | cellular response to unfolded protein(GO:0034620) |
0.1 | 0.2 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.2 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.1 | 0.1 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 0.2 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.1 | 0.1 | GO:0007127 | meiosis I(GO:0007127) |
0.1 | 0.2 | GO:0050932 | regulation of pigment cell differentiation(GO:0050932) |
0.1 | 0.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.6 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.1 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.1 | 0.1 | GO:0006188 | IMP biosynthetic process(GO:0006188) 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.1 | GO:0046831 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.1 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.1 | 0.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.8 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.3 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.1 | 0.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 14.2 | GO:0006412 | translation(GO:0006412) |
0.1 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.2 | GO:0050871 | positive regulation of B cell activation(GO:0050871) |
0.1 | 0.2 | GO:0010464 | regulation of mesenchymal cell proliferation(GO:0010464) |
0.1 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.2 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.1 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 1.6 | GO:0090132 | epithelium migration(GO:0090132) |
0.1 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.1 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.1 | 0.3 | GO:0006094 | gluconeogenesis(GO:0006094) |
0.1 | 0.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.3 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.1 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.1 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.1 | GO:0051025 | negative regulation of immunoglobulin production(GO:0002638) negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 0.1 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.1 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.2 | GO:0042102 | positive regulation of T cell proliferation(GO:0042102) |
0.1 | 0.1 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.1 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.1 | GO:0021636 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
0.1 | 0.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.3 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.0 | 0.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.0 | 0.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.1 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.0 | 0.0 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 0.0 | GO:0046364 | monosaccharide biosynthetic process(GO:0046364) |
0.0 | 0.0 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.0 | 0.4 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.1 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.0 | 0.4 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.3 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 0.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.0 | GO:0070199 | establishment of protein localization to chromosome(GO:0070199) |
0.0 | 0.6 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.1 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.5 | GO:0007051 | spindle organization(GO:0007051) |
0.0 | 0.0 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.0 | 0.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 2.0 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.1 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.2 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.0 | 0.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.2 | GO:2000785 | regulation of vacuole organization(GO:0044088) regulation of autophagosome assembly(GO:2000785) |
0.0 | 0.0 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.0 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.0 | 0.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.1 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.0 | 0.1 | GO:0032350 | regulation of hormone metabolic process(GO:0032350) |
0.0 | 0.8 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.3 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.0 | 0.0 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.0 | 0.0 | GO:0051610 | serotonin uptake(GO:0051610) |
0.0 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.1 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.0 | 0.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.0 | GO:0006476 | protein deacetylation(GO:0006476) |
0.0 | 0.0 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.0 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 0.0 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.0 | 0.2 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.0 | 0.4 | GO:0045010 | actin nucleation(GO:0045010) |
0.0 | 0.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.0 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.0 | 0.1 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.0 | 0.0 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.0 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.0 | 3.0 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.0 | 0.1 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.0 | GO:0046466 | membrane lipid catabolic process(GO:0046466) |
0.0 | 0.1 | GO:0072599 | establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 0.7 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.2 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.0 | GO:0090269 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) positive regulation of fibroblast growth factor production(GO:0090271) |
0.0 | 0.0 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.0 | 0.2 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.0 | 0.1 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.1 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.1 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.0 | 0.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 0.6 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.2 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.0 | 0.4 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.0 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.7 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.0 | 0.1 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.0 | 0.1 | GO:0032720 | negative regulation of tumor necrosis factor production(GO:0032720) |
0.0 | 0.5 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.0 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.0 | 6.3 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
0.0 | 0.1 | GO:0032329 | serine transport(GO:0032329) |
0.0 | 0.0 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.7 | GO:0006956 | complement activation(GO:0006956) |
0.0 | 0.3 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.0 | 0.2 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.1 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.2 | GO:0043506 | regulation of JUN kinase activity(GO:0043506) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.2 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.0 | 0.2 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.0 | 0.1 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.0 | 0.8 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.0 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.0 | 0.4 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.0 | 0.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.2 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 0.0 | GO:0051806 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.0 | 2.6 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.1 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.0 | 0.0 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.0 | 0.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 1.7 | GO:0006869 | lipid transport(GO:0006869) |
0.0 | 3.3 | GO:0051301 | cell division(GO:0051301) |
0.0 | 1.3 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.0 | 0.0 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.0 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.0 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.2 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.0 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.0 | GO:1900076 | regulation of cellular response to insulin stimulus(GO:1900076) |
0.0 | 0.1 | GO:0043584 | nose development(GO:0043584) |
0.0 | 0.0 | GO:0070542 | response to fatty acid(GO:0070542) |
0.0 | 1.9 | GO:0032496 | response to lipopolysaccharide(GO:0032496) |
0.0 | 0.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.0 | 0.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.1 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.0 | GO:0033083 | regulation of immature T cell proliferation(GO:0033083) |
0.0 | 0.0 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.0 | 0.0 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.0 | 0.0 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.2 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.0 | 0.0 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.0 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.0 | 0.0 | GO:0072498 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.0 | 0.1 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.0 | 0.0 | GO:1990182 | exosomal secretion(GO:1990182) |
0.0 | 0.0 | GO:0021557 | oculomotor nerve development(GO:0021557) trochlear nerve development(GO:0021558) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.4 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.1 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.0 | 4.5 | GO:0000122 | negative regulation of transcription from RNA polymerase II promoter(GO:0000122) |
0.0 | 0.0 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.1 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.1 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.6 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.0 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.0 | 0.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.1 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.0 | 0.0 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.0 | 0.2 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.0 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.0 | 0.0 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.0 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.0 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.0 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.0 | 0.0 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.0 | GO:0032675 | regulation of interleukin-6 production(GO:0032675) |
0.0 | 0.0 | GO:0048525 | negative regulation of viral process(GO:0048525) |
0.0 | 0.0 | GO:0046325 | negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
0.0 | 0.1 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.1 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
0.0 | 0.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.0 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.2 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 0.0 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.0 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.1 | GO:0048477 | oogenesis(GO:0048477) |
0.0 | 0.0 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.0 | GO:0017004 | cytochrome complex assembly(GO:0017004) respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.1 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 1.9 | GO:0007283 | spermatogenesis(GO:0007283) |
0.0 | 0.1 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.0 | 0.1 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.0 | GO:0010883 | regulation of lipid storage(GO:0010883) |
0.0 | 0.0 | GO:0051193 | regulation of cofactor metabolic process(GO:0051193) |
0.0 | 0.0 | GO:0016074 | snoRNA metabolic process(GO:0016074) |
0.0 | 0.0 | GO:1903203 | neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.7 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
2.3 | 18.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
1.5 | 4.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.5 | 6.1 | GO:0042825 | TAP complex(GO:0042825) |
1.5 | 6.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.4 | 4.2 | GO:0016234 | inclusion body(GO:0016234) |
1.4 | 1.4 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
1.3 | 3.9 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
1.2 | 7.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
1.2 | 8.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
1.1 | 5.7 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
1.1 | 4.3 | GO:0070876 | SOSS complex(GO:0070876) |
1.1 | 4.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.1 | 7.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.0 | 8.1 | GO:0005861 | troponin complex(GO:0005861) |
1.0 | 4.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
1.0 | 2.9 | GO:0000814 | ESCRT II complex(GO:0000814) |
1.0 | 10.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.9 | 4.7 | GO:0070695 | FHF complex(GO:0070695) |
0.9 | 1.9 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.9 | 4.4 | GO:0005827 | polar microtubule(GO:0005827) |
0.9 | 3.5 | GO:0033269 | internode region of axon(GO:0033269) |
0.9 | 8.7 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.9 | 6.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.8 | 7.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.8 | 6.7 | GO:0045179 | apical cortex(GO:0045179) |
0.8 | 2.5 | GO:0070552 | BRISC complex(GO:0070552) |
0.8 | 4.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.8 | 3.3 | GO:0071203 | WASH complex(GO:0071203) |
0.8 | 2.5 | GO:1990635 | proximal dendrite(GO:1990635) |
0.8 | 5.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.8 | 3.9 | GO:0016589 | NURF complex(GO:0016589) |
0.8 | 6.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.8 | 3.8 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.7 | 1.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.7 | 2.9 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.7 | 7.8 | GO:0001527 | microfibril(GO:0001527) |
0.7 | 3.5 | GO:0005638 | lamin filament(GO:0005638) |
0.7 | 2.8 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.7 | 5.5 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.7 | 4.8 | GO:0016272 | prefoldin complex(GO:0016272) |
0.7 | 1.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.7 | 2.7 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.7 | 3.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.7 | 5.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.6 | 3.2 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.6 | 7.5 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.6 | 2.4 | GO:0043296 | apical junction complex(GO:0043296) |
0.6 | 6.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.6 | 2.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.6 | 6.5 | GO:0031528 | microvillus membrane(GO:0031528) |
0.6 | 1.8 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.6 | 1.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.6 | 1.7 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.6 | 1.7 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.6 | 4.6 | GO:0002102 | podosome(GO:0002102) |
0.6 | 2.8 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.6 | 6.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.6 | 38.0 | GO:0016363 | nuclear matrix(GO:0016363) |
0.5 | 7.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 3.8 | GO:0032584 | growth cone membrane(GO:0032584) |
0.5 | 4.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.5 | 1.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.5 | 5.4 | GO:0032039 | integrator complex(GO:0032039) |
0.5 | 4.9 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.5 | 1.6 | GO:0097255 | R2TP complex(GO:0097255) |
0.5 | 2.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.5 | 1.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.5 | 6.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.5 | 1.0 | GO:1990423 | RZZ complex(GO:1990423) |
0.5 | 3.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.5 | 2.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.5 | 1.5 | GO:0000811 | GINS complex(GO:0000811) |
0.5 | 2.0 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.5 | 0.5 | GO:0005642 | annulate lamellae(GO:0005642) |
0.5 | 4.6 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.5 | 2.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.5 | 4.0 | GO:0001650 | fibrillar center(GO:0001650) |
0.5 | 1.4 | GO:0031672 | A band(GO:0031672) |
0.5 | 2.8 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.5 | 1.4 | GO:1990923 | PET complex(GO:1990923) |
0.5 | 1.9 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.5 | 1.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.5 | 4.7 | GO:0016580 | Sin3 complex(GO:0016580) |
0.5 | 8.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.5 | 0.9 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.5 | 0.9 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.5 | 1.8 | GO:0030897 | HOPS complex(GO:0030897) |
0.4 | 0.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.4 | 21.1 | GO:0016459 | myosin complex(GO:0016459) |
0.4 | 2.2 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.4 | 5.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.4 | 3.4 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.4 | 3.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 1.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.4 | 1.3 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.4 | 2.9 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.4 | 1.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.4 | 1.7 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.4 | 4.1 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.4 | 0.8 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.4 | 2.1 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.4 | 0.8 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 1.2 | GO:0072487 | MSL complex(GO:0072487) |
0.4 | 13.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.4 | 1.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.4 | 2.3 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.4 | 5.9 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.4 | 1.6 | GO:0005687 | U4 snRNP(GO:0005687) |
0.4 | 5.0 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.4 | 1.5 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.4 | 1.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.4 | 0.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.4 | 1.1 | GO:0000235 | astral microtubule(GO:0000235) |
0.4 | 1.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.4 | 1.9 | GO:0044194 | cytolytic granule(GO:0044194) |
0.4 | 1.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.4 | 2.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.4 | 1.9 | GO:0005795 | Golgi stack(GO:0005795) |
0.4 | 2.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.4 | 8.5 | GO:0000791 | euchromatin(GO:0000791) |
0.4 | 0.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.4 | 1.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.4 | 2.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.4 | 5.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.4 | 1.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.4 | 1.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.4 | 1.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 1.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 23.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 3.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 3.5 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.3 | 1.0 | GO:0071565 | nBAF complex(GO:0071565) |
0.3 | 8.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 11.5 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 1.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.3 | 1.6 | GO:0090544 | BAF-type complex(GO:0090544) |
0.3 | 2.9 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.3 | 0.7 | GO:0044393 | microspike(GO:0044393) |
0.3 | 0.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.3 | 1.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 3.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.3 | 2.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.3 | 2.9 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 2.9 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 2.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 1.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.3 | 2.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 3.4 | GO:0031430 | M band(GO:0031430) |
0.3 | 4.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.3 | 2.5 | GO:0097470 | ribbon synapse(GO:0097470) |
0.3 | 0.9 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.3 | 0.9 | GO:0000125 | PCAF complex(GO:0000125) |
0.3 | 0.9 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.3 | 0.9 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.3 | 3.0 | GO:0034709 | methylosome(GO:0034709) |
0.3 | 2.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 16.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 2.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 0.9 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.3 | 0.6 | GO:0042585 | germinal vesicle(GO:0042585) |
0.3 | 0.9 | GO:0097452 | GAIT complex(GO:0097452) |
0.3 | 0.6 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 0.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 0.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 0.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 3.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 4.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.3 | 2.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 3.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 5.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 5.1 | GO:0043034 | costamere(GO:0043034) |
0.3 | 1.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.3 | 2.0 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.3 | 0.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 2.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.3 | 61.5 | GO:0000785 | chromatin(GO:0000785) |
0.3 | 1.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.3 | 0.6 | GO:0090533 | sodium:potassium-exchanging ATPase complex(GO:0005890) cation-transporting ATPase complex(GO:0090533) |
0.3 | 1.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 1.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 6.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.3 | 3.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 11.4 | GO:0042641 | actomyosin(GO:0042641) |
0.3 | 1.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.3 | 5.7 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.3 | 11.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.3 | 1.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.3 | 0.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 2.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.3 | 1.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 0.8 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 2.6 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 2.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 0.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 1.0 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.3 | 2.1 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.3 | 2.9 | GO:0046930 | pore complex(GO:0046930) |
0.3 | 1.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.3 | 7.2 | GO:0072686 | mitotic spindle(GO:0072686) |
0.3 | 0.5 | GO:0005914 | spot adherens junction(GO:0005914) |
0.3 | 2.8 | GO:0051233 | spindle midzone(GO:0051233) |
0.3 | 1.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.3 | 1.3 | GO:0099738 | basal cortex(GO:0045180) cell cortex region(GO:0099738) |
0.3 | 8.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 0.7 | GO:0005712 | chiasma(GO:0005712) |
0.2 | 2.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 2.0 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 0.7 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 0.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 3.4 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 0.7 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 2.9 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 13.6 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.2 | 4.5 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 2.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 4.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 9.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 0.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 0.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 3.7 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 1.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 5.2 | GO:0008305 | integrin complex(GO:0008305) |
0.2 | 2.7 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 0.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 2.3 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 0.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 1.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 1.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.2 | 0.9 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 11.7 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.9 | GO:1990696 | USH2 complex(GO:1990696) |
0.2 | 1.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 0.7 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 1.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.9 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 5.7 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 1.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 3.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 1.7 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 0.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 0.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 2.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 3.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 13.8 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.2 | 0.4 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.2 | 0.8 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.2 | 0.2 | GO:0034399 | nuclear periphery(GO:0034399) |
0.2 | 0.2 | GO:0005818 | aster(GO:0005818) |
0.2 | 28.7 | GO:0031965 | nuclear membrane(GO:0031965) |
0.2 | 0.8 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 6.3 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.2 | 0.6 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 0.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 0.8 | GO:0071010 | prespliceosome(GO:0071010) |
0.2 | 21.3 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 0.6 | GO:0005839 | proteasome core complex(GO:0005839) |
0.2 | 0.6 | GO:0038201 | TOR complex(GO:0038201) |
0.2 | 8.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 1.2 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 2.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 0.6 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 1.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 0.6 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 1.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 7.2 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 6.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 3.8 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.2 | 0.4 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 0.6 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 0.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 0.8 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.2 | 0.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 0.7 | GO:0000938 | GARP complex(GO:0000938) |
0.2 | 0.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 2.9 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.2 | 1.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 0.9 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 1.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 0.4 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.2 | 0.5 | GO:0043203 | axon hillock(GO:0043203) |
0.2 | 6.0 | GO:0016605 | PML body(GO:0016605) |
0.2 | 0.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 4.0 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.2 | 12.9 | GO:0005903 | brush border(GO:0005903) |
0.2 | 13.6 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 6.2 | GO:0030496 | midbody(GO:0030496) |
0.2 | 0.7 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 0.5 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 0.7 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 6.5 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 0.3 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 2.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 0.2 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.2 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 1.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 0.5 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.2 | 5.6 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 5.7 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 2.0 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 0.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 0.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 5.5 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.2 | 0.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 0.8 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 1.8 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 2.9 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 12.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.2 | 3.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 0.6 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 9.6 | GO:0005814 | centriole(GO:0005814) |
0.2 | 11.7 | GO:0016604 | nuclear body(GO:0016604) |
0.2 | 4.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.2 | 172.1 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 0.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 5.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 0.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 0.5 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 3.6 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 0.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 4.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.9 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 1.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 2.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.3 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 3.9 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 1.5 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.7 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 119.0 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.5 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.4 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.5 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 1.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.8 | GO:0000801 | central element(GO:0000801) |
0.1 | 1.3 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 3.6 | GO:0044431 | Golgi apparatus part(GO:0044431) |
0.1 | 2.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 1.2 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 0.1 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 36.2 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.6 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 26.0 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 12.3 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.8 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.1 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.4 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.4 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.1 | 0.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.9 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 3.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.3 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 3.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 6.0 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 1.8 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.6 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 0.8 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 4.7 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 6.8 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 0.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 6.5 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.4 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.2 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 1.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 64.4 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.3 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.1 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.2 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 1.2 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 1.2 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 3.0 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 2.1 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 0.7 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 0.4 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 1.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 7.9 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 0.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 77.0 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.2 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.1 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.3 | GO:0030894 | replisome(GO:0030894) |
0.1 | 124.1 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 8.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.1 | GO:1904949 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.0 | 0.3 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.8 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.2 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.0 | 3.3 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 1.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.0 | 0.0 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 0.1 | GO:0098552 | side of membrane(GO:0098552) |
0.0 | 7.9 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.0 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.0 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.0 | GO:0022626 | cytosolic ribosome(GO:0022626) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 9.9 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
1.9 | 5.8 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
1.8 | 5.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
1.6 | 1.6 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
1.5 | 6.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.5 | 4.6 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.5 | 4.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.4 | 10.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.4 | 5.4 | GO:0009374 | biotin binding(GO:0009374) |
1.3 | 6.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.2 | 6.1 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
1.2 | 3.6 | GO:0030172 | troponin C binding(GO:0030172) |
1.2 | 4.7 | GO:0015232 | heme transporter activity(GO:0015232) |
1.1 | 3.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
1.1 | 3.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
1.1 | 5.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.0 | 3.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
1.0 | 4.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.0 | 4.0 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
1.0 | 3.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
1.0 | 4.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.0 | 4.9 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
1.0 | 11.7 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.0 | 3.8 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.9 | 2.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.9 | 2.8 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.9 | 3.8 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.9 | 2.8 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.9 | 7.5 | GO:1990405 | protein antigen binding(GO:1990405) |
0.9 | 11.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.9 | 3.7 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.9 | 4.6 | GO:0043820 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.9 | 3.6 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.9 | 4.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.9 | 8.0 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.9 | 4.4 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.9 | 2.6 | GO:0031433 | telethonin binding(GO:0031433) |
0.8 | 2.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.8 | 1.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.8 | 5.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.8 | 5.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.8 | 2.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.8 | 25.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.8 | 2.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.8 | 2.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.8 | 6.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.8 | 3.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.8 | 13.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.8 | 2.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.8 | 2.4 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.8 | 2.4 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.8 | 2.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.8 | 2.3 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.8 | 3.8 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.8 | 1.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.8 | 1.5 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.8 | 1.5 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.7 | 5.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.7 | 15.7 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.7 | 4.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.7 | 2.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.7 | 5.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.7 | 10.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.7 | 3.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.7 | 4.2 | GO:0015288 | porin activity(GO:0015288) |
0.7 | 10.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.7 | 2.8 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.7 | 2.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.7 | 4.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.7 | 2.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.7 | 2.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.7 | 6.7 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.7 | 4.6 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.7 | 6.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.7 | 2.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.7 | 2.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.7 | 2.6 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.7 | 11.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.6 | 1.9 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.6 | 0.6 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.6 | 8.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.6 | 5.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.6 | 30.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.6 | 0.6 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.6 | 4.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.6 | 1.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.6 | 5.5 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.6 | 9.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.6 | 3.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.6 | 6.0 | GO:0005522 | profilin binding(GO:0005522) |
0.6 | 5.4 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.6 | 3.6 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.6 | 2.4 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.6 | 2.9 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.6 | 9.2 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.6 | 2.8 | GO:0008199 | ferric iron binding(GO:0008199) |
0.6 | 1.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.6 | 1.1 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.6 | 1.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.6 | 5.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.5 | 2.7 | GO:0000150 | recombinase activity(GO:0000150) |
0.5 | 1.6 | GO:0048030 | disaccharide binding(GO:0048030) |
0.5 | 1.6 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.5 | 3.8 | GO:0046790 | virion binding(GO:0046790) |
0.5 | 7.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.5 | 2.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.5 | 1.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.5 | 2.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.5 | 5.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.5 | 3.6 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.5 | 2.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.5 | 2.6 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.5 | 9.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.5 | 4.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.5 | 8.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.5 | 2.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.5 | 1.5 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.5 | 1.5 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.5 | 2.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.5 | 3.0 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.5 | 1.5 | GO:0050693 | LBD domain binding(GO:0050693) |
0.5 | 1.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.5 | 1.0 | GO:0050692 | DBD domain binding(GO:0050692) |
0.5 | 3.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.5 | 2.0 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.5 | 2.0 | GO:0043426 | MRF binding(GO:0043426) |
0.5 | 3.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.5 | 1.0 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.5 | 14.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.5 | 1.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.5 | 1.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.5 | 4.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.5 | 1.0 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.5 | 1.4 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.5 | 4.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.5 | 1.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 1.4 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.5 | 8.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.5 | 1.8 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.5 | 9.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.5 | 1.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.4 | 1.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.4 | 2.7 | GO:0016936 | galactoside binding(GO:0016936) |
0.4 | 1.8 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.4 | 1.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.4 | 1.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.4 | 4.4 | GO:0005536 | glucose binding(GO:0005536) |
0.4 | 0.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 1.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.4 | 1.7 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.4 | 1.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 1.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.4 | 1.7 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.4 | 1.7 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.4 | 9.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.4 | 2.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 2.1 | GO:0043559 | insulin binding(GO:0043559) |
0.4 | 1.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.4 | 1.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.4 | 5.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.4 | 2.9 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.4 | 3.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 3.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.4 | 2.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.4 | 1.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.4 | 1.2 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.4 | 5.7 | GO:0043274 | phospholipase binding(GO:0043274) |
0.4 | 4.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.4 | 0.4 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.4 | 6.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.4 | 2.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.4 | 1.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.4 | 0.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.4 | 2.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.4 | 2.7 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.4 | 4.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.4 | 0.8 | GO:0070538 | oleic acid binding(GO:0070538) |
0.4 | 1.9 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.4 | 2.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 3.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.4 | 1.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.4 | 0.8 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.4 | 10.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.4 | 1.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.4 | 6.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.4 | 1.1 | GO:0019961 | interferon binding(GO:0019961) |
0.4 | 2.6 | GO:0034046 | poly(G) binding(GO:0034046) |
0.4 | 1.5 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.4 | 4.7 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.4 | 1.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.4 | 2.2 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.4 | 1.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.4 | 1.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.4 | 1.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.4 | 2.5 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.4 | 1.8 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.3 | 1.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 1.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.3 | 3.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.3 | 3.5 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.3 | 2.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 4.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 1.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 0.7 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.3 | 2.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 1.0 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.3 | 1.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.3 | 4.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 0.7 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 1.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.3 | 4.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.3 | 0.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 1.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.3 | 3.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 2.3 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.3 | 1.0 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.3 | 0.7 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.3 | 2.0 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.3 | 0.7 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 10.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.3 | 2.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.3 | 0.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.3 | 1.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 1.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.3 | 1.3 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.3 | 0.6 | GO:0038132 | neuregulin binding(GO:0038132) |
0.3 | 3.9 | GO:0031491 | nucleosome binding(GO:0031491) |
0.3 | 3.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 0.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.3 | 1.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.3 | 1.6 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 0.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 0.9 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.3 | 9.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.3 | 0.9 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.3 | 4.1 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.3 | 3.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.3 | 19.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.3 | 4.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.3 | 0.3 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.3 | 1.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 2.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 0.3 | GO:0045340 | mercury ion binding(GO:0045340) |
0.3 | 0.9 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.3 | 3.0 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.3 | 0.9 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.3 | 0.6 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.3 | 2.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 2.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.3 | 2.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 1.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 3.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.3 | 1.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.3 | 5.9 | GO:0043531 | ADP binding(GO:0043531) |
0.3 | 0.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 2.6 | GO:0071949 | FAD binding(GO:0071949) |
0.3 | 0.6 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.3 | 1.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 0.3 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.3 | 1.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 2.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 1.4 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.3 | 0.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.3 | 2.0 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.3 | 1.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 0.3 | GO:0030487 | inositol-4,5-bisphosphate 5-phosphatase activity(GO:0030487) |
0.3 | 0.6 | GO:0004096 | catalase activity(GO:0004096) |
0.3 | 0.9 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.3 | 1.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.3 | 0.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.3 | 0.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.3 | 4.8 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.3 | 0.8 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.3 | 8.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.3 | 0.6 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.3 | 9.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.3 | 1.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.3 | 15.3 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.3 | 1.7 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.3 | 0.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) palmitoyl-CoA oxidase activity(GO:0016401) |
0.3 | 4.4 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 1.1 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.3 | 4.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.3 | 1.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 1.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.3 | 4.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 1.4 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.3 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.3 | 1.6 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.3 | 0.5 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.3 | 2.1 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.3 | 18.7 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.3 | 1.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 10.9 | GO:0005507 | copper ion binding(GO:0005507) |
0.3 | 0.3 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.3 | 5.3 | GO:0045502 | dynein binding(GO:0045502) |
0.3 | 0.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.3 | 0.5 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 2.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.3 | 0.5 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.3 | 5.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 2.1 | GO:0046977 | TAP binding(GO:0046977) |
0.3 | 1.8 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.3 | 0.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 0.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.3 | 1.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.3 | 0.3 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.3 | 2.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 1.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.3 | 0.8 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.3 | 3.1 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 0.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.3 | 10.4 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.3 | 2.8 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
0.3 | 0.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 8.8 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.3 | 0.8 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.2 | 5.0 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 0.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 1.0 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.2 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.2 | 1.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 6.7 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 5.9 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.2 | 0.7 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.2 | 1.0 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 0.7 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 0.5 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 0.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.2 | 0.7 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 4.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 0.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.2 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 1.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 0.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 6.3 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.2 | 11.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 3.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 3.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.9 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 0.7 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 26.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.2 | 0.9 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 0.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.2 | 21.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 1.6 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 1.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 0.9 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 0.7 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 1.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 1.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 0.9 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 3.8 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.2 | 0.9 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 0.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.2 | 0.9 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 2.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 1.8 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 4.0 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 0.9 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 1.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 1.1 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.9 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 0.9 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 0.7 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 5.0 | GO:0043621 | protein self-association(GO:0043621) |
0.2 | 1.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 1.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 4.1 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 0.9 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 19.4 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.2 | 0.4 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.2 | 0.6 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.2 | 0.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 0.4 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.2 | 0.6 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.2 | 3.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 11.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 0.8 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 0.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 1.0 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 4.6 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.2 | 1.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 1.0 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 1.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 0.8 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 2.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 4.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 1.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 0.6 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.2 | 2.0 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 0.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 0.4 | GO:0005119 | smoothened binding(GO:0005119) |
0.2 | 5.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 0.4 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.2 | 0.4 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 1.2 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 1.8 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 0.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 0.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 0.6 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 1.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 1.0 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.2 | 0.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 4.3 | GO:0001047 | core promoter binding(GO:0001047) |
0.2 | 2.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 1.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 0.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 0.6 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 0.4 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.2 | 0.6 | GO:0070061 | fructose binding(GO:0070061) |
0.2 | 4.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 1.1 | GO:0060590 | ATPase activator activity(GO:0001671) ATPase regulator activity(GO:0060590) |
0.2 | 1.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 0.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.2 | 0.9 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 6.6 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.2 | 1.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 1.5 | GO:0035326 | enhancer binding(GO:0035326) |
0.2 | 0.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 1.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 0.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.2 | 0.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 0.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 0.6 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 5.5 | GO:0035064 | methylated histone binding(GO:0035064) |
0.2 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 3.9 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 0.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 0.7 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 1.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 1.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 3.5 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 0.7 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 1.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.2 | 0.4 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 1.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.7 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.2 | 0.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 0.4 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.2 | 1.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.2 | 1.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 6.8 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.2 | 7.8 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.2 | 5.5 | GO:0004386 | helicase activity(GO:0004386) |
0.2 | 0.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 3.2 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.2 | 3.5 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.2 | 0.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 1.2 | GO:0048029 | monosaccharide binding(GO:0048029) |
0.2 | 1.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 31.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 41.0 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.2 | 0.9 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.2 | 0.9 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 1.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 13.8 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.2 | 1.0 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 0.5 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 4.3 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.2 | 1.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 1.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 0.3 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.2 | 0.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 0.3 | GO:0035473 | lipase binding(GO:0035473) |
0.2 | 1.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 0.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 3.0 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 0.5 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.2 | 0.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 0.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 0.7 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 0.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 5.7 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.2 | 0.5 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.2 | 1.3 | GO:0018449 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 0.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 1.3 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.2 | 0.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 0.3 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 3.9 | GO:0050661 | NADP binding(GO:0050661) |
0.2 | 0.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 11.4 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 2.1 | GO:0009055 | electron carrier activity(GO:0009055) |
0.2 | 0.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.2 | 2.7 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 1.9 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.2 | 1.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 0.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 0.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.2 | 0.9 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.2 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 1.1 | GO:0034841 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.2 | 1.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.2 | 0.5 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 0.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 1.1 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 0.2 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.2 | 11.5 | GO:0051020 | GTPase binding(GO:0051020) |
0.2 | 0.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 2.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 1.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 4.0 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.4 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.3 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.6 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
0.1 | 1.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 5.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.3 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 3.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 2.5 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 1.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 2.7 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 5.6 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 4.0 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 1.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 0.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 1.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 25.9 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 31.5 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.7 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 2.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 2.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 1.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 1.8 | GO:0046961 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 11.7 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 2.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.3 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 2.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.5 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 1.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 13.5 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 0.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 3.6 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 0.4 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.9 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 0.4 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 3.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 0.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.3 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 8.9 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.1 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.2 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 0.9 | GO:0015321 | sodium:phosphate symporter activity(GO:0005436) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 2.2 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.1 | 1.6 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.2 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 0.6 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.4 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.5 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 1.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 1.0 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 1.3 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 0.1 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.1 | 0.5 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 13.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.5 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.7 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 6.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 2.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 1.4 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 1.0 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 4.5 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 20.1 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.1 | 0.9 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 2.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 2.1 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.6 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 12.2 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 7.8 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.1 | 1.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.9 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.6 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.4 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.1 | 0.4 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 0.1 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.1 | 1.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 1.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 2.0 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.4 | GO:0102344 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 7.6 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.3 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 3.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 7.9 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.1 | 0.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 1.6 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.1 | 0.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.8 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 1.4 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 1.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.5 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
0.1 | 0.9 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 2.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.1 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 0.1 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.1 | 0.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.6 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 1.8 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.3 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 2.8 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 3.0 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.1 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 1.1 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.1 | 2.0 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 3.4 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 1.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 1.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 1.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.2 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 18.1 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 0.6 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 0.1 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.1 | 0.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 9.0 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 0.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 1.0 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.9 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 3.2 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.1 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 0.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 5.1 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.1 | 3.4 | GO:0005506 | iron ion binding(GO:0005506) |
0.1 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.1 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 1.5 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.1 | 0.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 0.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 1.1 | GO:0060090 | binding, bridging(GO:0060090) |
0.1 | 6.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.5 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 0.3 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 1.0 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.1 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.1 | 0.9 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.4 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.1 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 39.5 | GO:0003677 | DNA binding(GO:0003677) |
0.1 | 0.1 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.1 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 2.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.1 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 1.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.3 | GO:0042288 | MHC protein binding(GO:0042287) MHC class I protein binding(GO:0042288) |
0.0 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 17.3 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.0 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 4.2 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 2.8 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.0 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.0 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 4.1 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.3 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.2 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.0 | 0.1 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 2.0 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.0 | 0.6 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.0 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.3 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.0 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.0 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.5 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 1.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.8 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.0 | 0.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.0 | 0.1 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.0 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.0 | 0.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.0 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.0 | 0.1 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 0.0 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.0 | 0.0 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.0 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 0.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.0 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.0 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.0 | 0.0 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.4 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.0 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 9.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.9 | 22.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.8 | 15.4 | PID IGF1 PATHWAY | IGF1 pathway |
0.8 | 23.5 | PID EPO PATHWAY | EPO signaling pathway |
0.7 | 1.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.7 | 27.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.7 | 9.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.6 | 15.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.6 | 2.9 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.6 | 5.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.6 | 2.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.5 | 19.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.5 | 13.9 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.5 | 7.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.5 | 2.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.5 | 7.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.4 | 4.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.4 | 2.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.4 | 7.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 6.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 3.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 10.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.4 | 2.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 5.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 27.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.4 | 1.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 7.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.4 | 14.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.4 | 5.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 4.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.4 | 1.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 3.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.4 | 3.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 17.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.4 | 1.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.4 | 5.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.4 | 3.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.4 | 0.7 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.4 | 2.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 5.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.3 | 1.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.3 | 6.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 0.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.3 | 9.0 | PID ATR PATHWAY | ATR signaling pathway |
0.3 | 17.9 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.3 | 1.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 5.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 4.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 1.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 0.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 6.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 0.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 2.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 1.8 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.3 | 0.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 8.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.3 | 2.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.3 | 4.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 2.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.3 | 2.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 1.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 1.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 0.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 8.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 8.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.3 | 10.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.3 | 1.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.3 | 8.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.3 | 9.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 0.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 1.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 5.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 6.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 1.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 3.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 2.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 2.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 2.8 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 3.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 0.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 4.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 2.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 0.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 1.0 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 0.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 0.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 2.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 1.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 0.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 2.2 | PID ATM PATHWAY | ATM pathway |
0.2 | 2.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 3.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 0.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 1.4 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 1.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 2.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 1.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 2.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 1.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 3.2 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 8.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 2.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 4.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 1.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 1.9 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 1.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 2.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 1.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 2.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 0.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.8 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 13.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 1.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 7.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 0.7 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 0.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 8.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.3 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 7.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.6 | 14.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.0 | 10.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.9 | 8.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.8 | 9.6 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.7 | 11.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.7 | 0.7 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.7 | 9.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.6 | 7.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.6 | 6.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.6 | 5.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.6 | 6.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.6 | 15.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.6 | 16.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.6 | 9.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.6 | 9.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.5 | 13.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.5 | 5.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.5 | 23.7 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.5 | 8.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.5 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.5 | 3.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.5 | 2.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.5 | 12.6 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.5 | 1.9 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.5 | 11.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.5 | 23.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.4 | 7.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 6.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.4 | 7.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.4 | 4.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 0.8 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.4 | 10.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.4 | 4.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.4 | 6.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.4 | 2.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.4 | 3.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.4 | 0.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.4 | 3.5 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.4 | 2.7 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.4 | 8.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.4 | 4.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.4 | 4.8 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.4 | 1.5 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.4 | 2.9 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.4 | 5.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.4 | 8.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.4 | 1.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.4 | 3.5 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.3 | 6.6 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.3 | 2.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.3 | 6.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.3 | 31.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 3.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 22.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 3.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 0.7 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 1.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 14.4 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.3 | 3.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 3.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.3 | 4.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 0.6 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.3 | 6.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.3 | 4.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 3.8 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.3 | 12.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 2.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 1.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 0.3 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.3 | 6.4 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.3 | 2.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 10.4 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.3 | 6.9 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 8.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 7.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 2.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.3 | 5.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.3 | 2.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 0.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 9.8 | REACTOME TRANSLATION | Genes involved in Translation |
0.3 | 3.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 6.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 0.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 1.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 4.8 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.2 | 5.5 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.2 | 1.2 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.2 | 4.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 4.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 2.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 11.7 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 1.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 0.9 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 4.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 2.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 1.9 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.2 | 1.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 2.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 3.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 0.6 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 4.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.2 | 0.4 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.2 | 1.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 2.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 1.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 0.4 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.2 | 1.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 0.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 6.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 5.7 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 0.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 8.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 1.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 8.2 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 1.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 0.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 2.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 1.9 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.2 | 0.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 3.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 0.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 2.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 0.7 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 2.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 1.0 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.2 | 1.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 1.6 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 3.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 2.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 1.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 1.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 2.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 8.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 7.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 0.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 0.8 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.2 | 9.3 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.2 | 0.9 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.2 | 9.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.2 | 1.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 1.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 1.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 0.6 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 0.6 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.9 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 4.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 4.2 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 17.3 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.1 | 1.9 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 0.4 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 0.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.8 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 1.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.8 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 3.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 2.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 3.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.4 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 2.7 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.1 | 0.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 1.1 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.1 | 1.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 8.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 1.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 1.6 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 3.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.3 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 1.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.5 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 3.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 0.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 0.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 2.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.0 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.1 | 0.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 1.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.2 | REACTOME SIGNALLING TO ERKS | Genes involved in Signalling to ERKs |
0.1 | 0.2 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 2.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 1.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 3.3 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 2.2 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 0.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 0.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.3 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 1.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.3 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.1 | 0.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 0.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 0.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.3 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 0.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.2 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.5 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.0 | 0.8 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.0 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.0 | 0.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.5 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.0 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.0 | REACTOME INSULIN RECEPTOR SIGNALLING CASCADE | Genes involved in Insulin receptor signalling cascade |
0.0 | 0.3 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.0 | 0.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.0 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.2 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.0 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |